Best Investments/trading ideas for the weekJoin our free webinar on September23,2026.
Let's get started...
Best Investments/trading ideas for the weekJoin our free webinar on September23,2026.
Let's get started...
| Role | Insider | Date | Transaction | Value | Shares |
|---|---|---|---|---|---|
| CFO | Verghese Vikram | Sep 3, 2026 | Sell | $1.37M | 27,540 |
| CFO | Verghese Vikram | Sep 2, 2026 | Sell | $297.33K | 5,876 |
| CEO | Farquhar John C.M. | Aug 21, 2026 | Sell | $1.36M | 27,230 |
| CEO | Farquhar John C.M. | Aug 18, 2026 | Sell | $1.47M | 32,676 |
| Chief Medical Officer | Rogers Campbell | Aug 17, 2026 | Sell | $380.1K | 9,219 |
| CEO | Farquhar John C.M. | Aug 14, 2026 | Sell | $607.77K | 15,560 |
| CEO | Farquhar John C.M. | Aug 10, 2026 | Sell | $638.73K | 22,562 |
| Chief Medical Officer | Rogers Campbell | Jul 15, 2026 | Sell | $237.11K | 9,219 |
| CEO | Farquhar John C.M. | Jul 10, 2026 | Sell | $626.1K | 22,562 |
| CEO | Farquhar John C.M. | Jun 24, 2026 | Sell | $1.36M | 38,900 |
| CEO | Farquhar John C.M. | Jun 10, 2026 | Sell | $643.02K | 22,562 |
| Chief Medical Officer | Rogers Campbell | May 18, 2026 | Sell | $261.27K | 9,219 |
| CEO | Farquhar John C.M. | May 11, 2026 | Sell | $657.01K | 22,562 |
| 10% Owner | Bain Capital Life Sciences Investors, LLC | Apr 30, 2026 | Sell | $26.04M | 892,533 |
| 10% Owner | Bain Capital Life Sciences Investors, LLC | Apr 30, 2026 | Sell | $1.69M | 56,224 |
| 10% Owner | Bain Capital Life Sciences Investors, LLC | Apr 29, 2026 | Sell | $23.41M | 797,133 |
| 10% Owner | Bain Capital Life Sciences Investors, LLC | Apr 28, 2026 | Sell | $7.75M | 254,110 |
| CEO | Farquhar John C.M. | Apr 10, 2026 | Sell | $602.86K | 22,562 |
| Chief Medical Officer | Rogers Campbell | Apr 1, 2026 | Sell | $1.59M | 64,533 |
| Chief Medical Officer | Rogers Campbell | Mar 19, 2026 | Sell | $1.66M | 64,533 |
| CEO | Farquhar John C.M. | Mar 18, 2026 | Sell | $243.13K | 9,725 |
| CEO | Farquhar John C.M. | Mar 10, 2026 | Sell | $290.89K | 12,837 |
| Director | Cullivan Julie A | Mar 5, 2026 | Sell | $228.05K | 9,122 |
| Chief Medical Officer | Rogers Campbell | Feb 12, 2026 | Sell | $1.6M | 65,153 |
| CEO | Farquhar John C.M. | Feb 10, 2026 | Sell | $619.55K | 22,562 |
Open-market purchases and sales reported on SEC form 4 over the last 10years. Awards, option exercises, gifts and other non-market form 4 activity are excluded. Chart markers group a day's filings by direction; the table lists each filing.
